Toward understanding insulin fibrillation

Journal of Pharmaceutical Sciences

Volumn 86, Issue 5, 1997, Pages 517-525

  Brange, Jens ^a   Andersen, Lennart ^a   Laursen, Erik D ^a   Meyn, Giorgio ^a   Rasmussen, Eigil ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE INSULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PIG INSULIN;

ANTIBODY PRODUCTION; ARTICLE; DRUG STRUCTURE; HORMONE STRUCTURE; IMMUNIZATION; INSULIN METABOLISM; NONHUMAN; RABBIT; SPECIES DIFFERENCE; STRUCTURE ANALYSIS;

EID: 0030959947     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960297s     Document Type: Review

References (78)

1. Banting, F. G.; Best, C. H. J. Lab. Clin. Med. 1922, 7, 464-472.
2. Bischoff, F.; Sahyun, M. J. Biol. Chem. 1929, 81, 167-173.
3. Blatherwick, N. R.; Bischoff, F.; Maxwell, L. C.; Berger, J.; Sahyun, M. J. Biol. Chem. 1927, 72, 57-89.
4. Krogh, A.; Hemmingsen, A. M. Biochem. J. 1928, 22, 1231-1238.
5. Waugh, D. F. J. Am. Chem. Soc. 1946, 68, 247-250.
6. Dickens, F.; Dodds, E. C.; Lawson, W.; Maclagan, N. F. Biochem. J. 1927, 21, 560-571.
7. Vigneaud, V.,du; Geiling, E. M. K.; Eddy, C. A. J. Pharmacol Exp. Ther. 1928, 33, 497-509.
8. Gerlough, T. D.; Bates, R. W. J. Pharmacol. Exp. Ther. 1932, 45, 19-51.
9. Vigneaud, V.,du; Sifferd, R. H.; Sealock, R. R. J. Biol. Chem. 1933, 102, 521-533.
10. Langmuir, I.; Waugh, D. F. J. Am. Chem. Soc. 1940, 62, 2771-2793.
11. Waugh, D. F. Am. J. Physiol. 1941, 133, P484-P485.
12. Waugh, D. F. Fed. Proc. 1946, 5, 111.
13. Waugh, D. F.; Wilhelmson, D. F.; Commerford, S. L.; Sackler, M. L. J. Am. Chem. Soc. 1953, 75, 2592-2600.
14. Waugh, D. F. J. Cell. Comp. Physiol. 1957, 49 (Suppl.1), 145-164.
15. Waugh, D. F. J. Am. Chem. Soc. 1944, 66, 663.
16. Burke, M. J.; Rougvie, M. A. Biochemistry 1972, 11, 2435-2439.
17. Waugh, D. F. Adv. Protein Chem. 1954, 9, 325-437.
18. Brange, J.; Havelund, S.; Hommel, E.; Sorensen, E.; Kühl, C. Diabetic Med. 1986, 3, 532-536.
19. Dathe, M.; Gast K.; Zirwer, D.; Welfle, H.; Mehlis, B. Int. J. Pept. Protein Res. 1990, 36, 344-349.
20. Sluzky, V.; Tamada, J. A.; Klibanov, A. M.; Langer, R. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 9377-9381, 1991.
21. Sluzky, V.; Klibanov, A. M.; Langer, R. Biotechnol. Bioeng. 1992, 40, 895-903.
22. Brange, J.; Havelund, S.; Hansen, P.; Langkjaer, L.; Sørensen, E.; Hildebrandt, P. In Hormone Drugs, Gueriguian, J. L., Bransome, E. D., Outschoorn, A. S., Eds.; US Pharmacopoeial Convention: Rockville, MD, 1982; pp 96-105.
23. Brange, J.; Havelund, S.; Hougaard, P. Pharm. Res. 1992, 9, 727-734.
24. Costantino, H. R.; Langer, R.; Klibanov, A. M. Pharm. Res. 1994, 11, 21-29.
25. Brange, J.; Havelund, S. In Artificial Systems for Insulin Delivery; Brunetti, P., Alberti, K. G. M. M., Albisser, A. M., Hepp, K. D., Benedetti, M. M., Eds.; Raven: New York, 1983; pp 83-88.
26. Brange, J.; Hansen, J. F.; Havelund, S.; Melberg, S. G. In Advanced Models for the Therapy of Insulin-Dependent Diabetes; Brunetti, P., Waldhäusl, W. K., Eds.; Raven: New York, 1987; pp 85-90.
27. Blundell, T.; Dodson, G.; Hodgkin, D.; Mercola, D. Adv. Protein Chem. 1972, 26, 279-402.
28. Chawla, A. S.; Hinberg, I.; Biais, P.; Johnson, D. Diabetes 1985, 34, 420-424.
29. Feingold, V.; Jenkins, A. B.; Kraegen, E. W. Diabetologia 1984, 27, 373-378.
30. Farrant, J. L.; Mercer, E. H. Biochim. Biophys. Acta 1952, 8, 355-359.
31. Glenner, G. G.; Eanes, E. D.; Bladen, H. A.; Linke, R. P.; Termine, J. D. J. Histochem. Cytochem. 1974, 22, 1141-1158.
32. Kung, T. H.; Tsao, T. C. Sci. Sin. 1964, 13, 471-478.
33. Ambrose, E. J.; Elliott, A. Proc. R. Soc. (London) 1951, 208, 75-90.
34. Koltun, W. L.; Waugh, D. F.; Bear, R. S. J. Am. Chem. Soc. 1954, 76, 413-417.
35. Yu, N. T.; Jo, B. H.; Chang, R. C. C.; Huber, J. D. Arch. Biochem. Biophys. 1974, 160, 614-622.
36. Turnell, W. G.; Finch, J. T. J. Mol. Biol. 1992, 227, 1205-1223.
37. Brange, J.; Skelbaek-Pedersen, B.; Langkjaer, L.; Damgaard, U.; Ege, H.; Havelund, S.; Heding, L. G.; Jørgensen, K. H.; Lykkeberg, J.; Markussen, J.; Pingel, M.; Rasmussen, E. Galenics of Insulin: The Physico-chemical and Pharmaceutical Aspects of Insulin and Insulin Preparations, Springer: Berlin, 1987.
38. Hutchison, K. G. J. Pharm. Pharmacol. 1985, 37, 528-531.
39. Waugh, D. F.; Smith, M. J.; Fearing, D. F. Fed. Proc. 1948, 7, 131.
40. Vigneaud, V.,du J. Biol. Chem. 1931, 92, liv-llv.
41. Lens, J. J. Biol. Chem. 1947, 169, 313-322.
42. Pettinga, C. W. Biochem. Prep. 1958, 6, 28-31.
43. Perry, E. K.; Oakley, A. E.; Candy, J. M.; Perry, R. H. Neurosci. Lett. 1981, 25, 321-325.
44. Pinckard, R. N.; Weir, D. M.; McBride, W. H. Clin. Exp. Immunol. 1967, 2, 331-341.
45. Moore, W. V.; Leppert, P. J. Clin. Endocrinol. Metab. 1980, 51, 691-697.
46. Robbins, D. C.; Cooper, S. M.; Fineberg, S. E.; Mead, P. M. Diabetes 1987, 36, 838-841.
47. Ratner, R. E.; Phillips, T. M.; Steiner, M. Diabetes 1990, 39, 728-733.
48. Pietri, A.; Raskin, P. Diabetes Care, 1981, 4, 624-626.
49. Schlichtkrull, J.; Brange, J.; Christiansen, A. H.; Hallund, O.; Heding L. G.; Jørgensen, K. H. Horm. Metab. Res. 1974, 5 (Suppl. Ser.) 134-143.
50. Diamant, B.; Shamkant, P. Int. Archs. Allergy Appl. Immun. 1982, 67, 13-17.
51. Mommaerts, W. F. H. M.; Neurath, H. J. Biol. Chem. 1950, 185, 909-917.
52. Jensen, H.; Evans, E. A., Jr.; Pennington, W. D.; Schock, E. D. J. Biol.Chem. 1936, 114, 199-208.
53. Porter, R. R. Biochem. J. 1950, 46, 304-307.
54. Baker, E. N.; Blundell, T. L.; Cutfield, J. F.; Cutfield, S. M.; Dodson, E. J.; Dodson, G. G.; Hodgkin, D. M. C.; Hubbard, R. E.; Isaacs, N. W.; Reynolds, C. D.; Sakabe, K.; Sakabe, N. Vijayan, N. M. Phil. Trans. R. Soc. 1988, 319, 369-456.
55. Turenll, W. G.; Finch, J. T. J. Mol. Biol. 1992, 227, 1205-1223.
56. Derewenda, U.; Derewenda, Z.; Dodson E.; Dodson, G. G.; Reynolds, C. D.; Smith, G. D.; Sparks, C.; Swenson, D. Nature 1989, 338, 594-596.
57. Hua, Q.; Weiss, M. A. Biochemistry 1991, 30, 5505-5515.
58. Millican, R. L.; Brems, D. N. Biochemistry 1994, 33, 1116-1124.
59. Brange, J.; Dodson, G. G.; Edwards, D. J.; Holden, P. H.; Whittingham, J. L. Proteins, in press.
60. Buchwald, H.; Varco, R. L.; Rupp, R. L.; Goldenberg, F. J.; Barbosa, J.; Rohde, T. D.; Schwartz, R. A.; Rublein, T. G.; Blackshear, P. J. Lancet 1981, 1, 1233-1235.
61. Irsigler, K.; Kritz, H. Diabetes 1979, 28, 196-203.
62. James, D. E.; Jenkins, A. B.; Kraegen, E. W.; Chisholm, D. J. Diabetologia 1981, 21, 554-557.
63. Lougheed, W. D.; Woulfe-Flanagan, H.; Clement, J. R.; Albisser, A. M. Diabetologia 1980, 19, 1-9.
64. Brange, J. Stability of Insulin. Studies on the Physical and Chemical Stability of Insulin in Pharmaceutical Formulation; Plenum: London, 1994.
65. Brange, J.; Havelund, S. In Artificial Systems for Insulin Delivery; Brunetti, P., Alberti, K. G. M. M., Albisser, A. M., Hepp, K. D., Benedetti, M. M., Eds.; Raven: New York, 1983; pp 83-88.
66. Howell, S. L.; Tyhurst, M.; Duvefelt, H.; Andersson, A.; Hellerström, C. Cell. Tissue Res. 1978, 188, 107-118.
67. Derewenda, U.; Derewenda, Z.; Dodson E. J.; Dodson, G. G.; Bing, X.; Markussen, J. J. Mol. Biol. 1991, 220, 425-433.
68. Brange, J.; Havelund, S. Acta Med. Scand. 1983, 671 (Suppl.), 135-138.
69. Katakam, M.,; Banga, A. J.; PDA J. Pharm. Sci. Technol. 1995, 49, 160-165.
70. Blackshear, P. J.; Rohde, T. D.; Palmer, J. L.; Wigness, B. D.; Rupp, W. M.; Buchwald, H. Diabetes Care 1983, 6, 387-392.
71. Grau, U.; Saudek, C. D. Diabetes 1987, 36, 1453-1459.
72. Thurow, H.; Geisen, K. Diabetologia 1984, 27, 212-218.
73. Hansen, P. E.; Brange, J.; Havelund, S. US patent 4,614,730, 1986.
74. Brewster, M. E.; Hora, M. S.; Simkins, J. W.; Bodor, N. Pharm. Res. 1991, 8, 792-795.
75. Banga, A. K.; Mitra, R. J. Drug Targeting 1993, 1, 341-345.
76. Grau, U.; Geisen, K.; Jährling, P. Diabetes Nutr. Metab. 1989, 2, 43-52.
77. Pongor, S.; Brownlee, M.; Cerami, A. Diabetes 1983, 32, 1087-1091.
78. Brange, J.; Langkjær, L. In Stability and Characterization of Protein and Peptide Drugs: Case Histories; Wang, Y. J., Pearlman, R., Eds.; Plenum: New York, 1993; pp 315-350.